Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
LifeMD (LFMD) Stock Price & Analysis
378 Followers
LFMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.40 - $12.01
Previous Close$9.92
Volume8.86K
Average Volume (3M)643.63K
Market Cap
$389.48M
Enterprise Value$375.76M
Total Cash (Recent Filing)$33.15M
Total Debt (Recent Filing)$18.93M
Price to Earnings (P/E)-14.1
Beta2.20
Next Earnings
May 10, 2024EPS Estimate
-$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.70
Shares Outstanding40,366,047
10 Day Avg. Volume487,482
30 Day Avg. Volume643,629
Standard Deviation0.48
R-Squared0.03
Alpha0.09
Financial Highlights & Ratios
Price to Book (P/B)-34.33
Price to Sales (P/S)2.63
Price to Cash Flow (P/CF)17.00
P/FCF Ratio21.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.69
Enterprise Value/Gross Profit2.49
Enterprise Value/Ebitda5.26
Forecast
1Y Price Target
$12.00Price Target Upside20.48% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
LifeMD News
Bulls Say, Bears Say
Bulls Say
Financial GuidanceManagement increased the lower end of FY24 guidance, raising it to at least $200M, continuing to highlight growth expectations going forward.
Market ReactionAnalyst views the sell-off of LFMD's stock as an overreaction and sees it as an opportunity to buy at a dip.
Strategic PartnershipsLFMD partnership with health and wellness market leader Medifast (MED) aims to expand patient weight management and cross-selling opportunities.
Bears Say
Company PerformanceWorkSimpli 4Q revenue declining by -4.7% to $13.6M.
Market CompetitionNew market entrants like Costco's partnership with Sesame Health indicate increasing competition in the telehealth and weight loss drug market.
Stock Market ReactionLFMD's stock experienced an intraday selloff of -32%, indicating a negative market reaction to LillyDirect's announcement.
---
Ownership Overview
25.07% Insiders
5.17% Mutual Funds
5.89% Other Institutional Investors
63.86% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LFMD FAQ
What was LifeMD’s price range in the past 12 months?
LifeMD lowest stock price was $1.40 and its highest was $12.01 in the past 12 months.
What is LifeMD’s market cap?
Currently, no data Available
When is LifeMD’s upcoming earnings report date?
LifeMD’s upcoming earnings report date is May 10, 2024 which is in 21 days.
How were LifeMD’s earnings last quarter?
LifeMD released its earnings results on Mar 11, 2024. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.14 by $0.02.
Is LifeMD overvalued?
According to Wall Street analysts LifeMD’s price is currently Undervalued.
Does LifeMD pay dividends?
LifeMD does not currently pay dividends.
What is LifeMD’s EPS estimate?
LifeMD’s EPS estimate is -$0.15.
How many shares outstanding does LifeMD have?
LifeMD has 40,366,047 shares outstanding.
What happened to LifeMD’s price movement after its last earnings report?
LifeMD reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.14. Following the earnings report the stock price went up 5.409%.
Which hedge fund is a major shareholder of LifeMD?
Among the largest hedge funds holding LifeMD’s share is Royce & Associates LLC. It holds LifeMD’s shares valued at 7M.
---
LifeMD Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.00 (20.48% Upside)
$12.00 (20.48% Upside)
Blogger Sentiment
Bullish
LFMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 246.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
523.89%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
127.85%
Trailing 12-Months
Company Description
LifeMD
Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.
---
LFMD Company Deck
---
LFMD Earnings Call
Q4 2024
0:00 / 0:00
---
LFMD Stock 12 Months Forecast
Average Price Target
$12.00
▲(20.48% Upside)
Technical Analysis
Best Analysts Covering LFMD
1 Year
1 Year Success Rate
12/26 ratings generated profit
1 Year Average Return
+46.62%
reiterated a buy rating last month
Copying David Larsen's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of +46.62% per trade.
---